Company / Interest Expense per Share
X4 Pharmaceuticals, Inc Interest Expense per Share History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.10
FY2022
5-year range
$0.04 / $0.13
FY2018-FY2022
Trend
-27.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.04 to $0.10 over the past 2 years.
Based on SEC 10-K filings.
0.10 in FY2022.
Increased from $0.04 to $0.10 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, interest expense per share decreased 27.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2022 | $0.10 | -27.4% |
| FY2021 | $0.13 | +195.0% |
| FY2020 | $0.04 | -74.6% |
| FY2018 | $0.18 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026